SI21256A - Stabilizacija profila sproščanja učinkovin iz formulacije - Google Patents
Stabilizacija profila sproščanja učinkovin iz formulacije Download PDFInfo
- Publication number
- SI21256A SI21256A SI200200179A SI200200179A SI21256A SI 21256 A SI21256 A SI 21256A SI 200200179 A SI200200179 A SI 200200179A SI 200200179 A SI200200179 A SI 200200179A SI 21256 A SI21256 A SI 21256A
- Authority
- SI
- Slovenia
- Prior art keywords
- active substance
- physical pretreatment
- active ingredient
- clarithromycin
- pretreatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/521,295 US20060083759A1 (en) | 2002-07-17 | 2002-07-15 | Stabilization of the profile of release of active substances from a formulation |
SI200200179A SI21256A (sl) | 2002-07-17 | 2002-07-17 | Stabilizacija profila sproščanja učinkovin iz formulacije |
PCT/SI2003/000025 WO2004006888A2 (en) | 2002-07-17 | 2003-07-15 | Stabilization of the profile of release of active substances from a formulation |
AU2003248615A AU2003248615B2 (en) | 2002-07-17 | 2003-07-15 | Stabilization of the profile of release of active substances from a formulation |
UAA200500254A UA89020C2 (ru) | 2002-07-17 | 2003-07-15 | Способ изготовления ядра таблетки кларитромицина, ядро и фармацевтическая композиция |
YUP-2005/0038A RS20050038A (en) | 2002-07-17 | 2003-07-15 | Stabilization of the profile of release of active substances from a formulation |
EP03764288A EP1524965A2 (en) | 2002-07-17 | 2003-07-15 | Stabilization of the profile of release of active substances from a formulation |
PL03372771A PL372771A1 (en) | 2002-07-17 | 2003-07-15 | Stabilization of the profile of release of active substances from a formulation |
RU2005104423/15A RU2354387C2 (ru) | 2002-07-17 | 2003-07-15 | Стабилизация профиля высвобождения активного вещества из лекарственной формы |
HR20050040A HRP20050040A2 (en) | 2002-07-17 | 2005-01-14 | Stabilization of the profile of release of active supstances from a formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200200179A SI21256A (sl) | 2002-07-17 | 2002-07-17 | Stabilizacija profila sproščanja učinkovin iz formulacije |
Publications (1)
Publication Number | Publication Date |
---|---|
SI21256A true SI21256A (sl) | 2004-02-29 |
Family
ID=30113493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200200179A SI21256A (sl) | 2002-07-17 | 2002-07-17 | Stabilizacija profila sproščanja učinkovin iz formulacije |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060083759A1 (ru) |
EP (1) | EP1524965A2 (ru) |
AU (1) | AU2003248615B2 (ru) |
HR (1) | HRP20050040A2 (ru) |
PL (1) | PL372771A1 (ru) |
RS (1) | RS20050038A (ru) |
RU (1) | RU2354387C2 (ru) |
SI (1) | SI21256A (ru) |
UA (1) | UA89020C2 (ru) |
WO (1) | WO2004006888A2 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2283824B1 (en) * | 2009-07-30 | 2017-04-19 | Special Products Line S.p.A. | Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin |
CN108853039B (zh) * | 2018-08-07 | 2021-03-09 | 河北君临药业有限公司 | 一种克拉霉素分散片及其生产工艺 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1236023A (en) * | 1984-07-18 | 1988-05-03 | Yegnaswami Raghunathan | Controlled release pharmaceutical preparations |
GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US5009895A (en) * | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
CA2039742A1 (en) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Tablet composition and method for problem pharmaceutical materials |
US5599556A (en) * | 1991-12-31 | 1997-02-04 | Abbott Laboratories | Prolamine coatings for taste masking |
US5919489A (en) * | 1995-11-01 | 1999-07-06 | Abbott Laboratories | Process for aqueous granulation of clarithromycin |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
SI20150A (sl) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina |
BR0109194A (pt) * | 2000-03-15 | 2003-02-11 | Hanmi Pharm Ind Co Ltd | Método para preparar claritromicina em cristais da forma ii |
US6899890B2 (en) * | 2002-03-20 | 2005-05-31 | Kv Pharmaceutical Company | Bioadhesive drug delivery system |
-
2002
- 2002-07-15 US US10/521,295 patent/US20060083759A1/en not_active Abandoned
- 2002-07-17 SI SI200200179A patent/SI21256A/sl not_active IP Right Cessation
-
2003
- 2003-07-15 UA UAA200500254A patent/UA89020C2/ru unknown
- 2003-07-15 AU AU2003248615A patent/AU2003248615B2/en not_active Ceased
- 2003-07-15 EP EP03764288A patent/EP1524965A2/en not_active Withdrawn
- 2003-07-15 WO PCT/SI2003/000025 patent/WO2004006888A2/en not_active Application Discontinuation
- 2003-07-15 PL PL03372771A patent/PL372771A1/xx not_active Application Discontinuation
- 2003-07-15 RU RU2005104423/15A patent/RU2354387C2/ru not_active IP Right Cessation
- 2003-07-15 RS YUP-2005/0038A patent/RS20050038A/sr unknown
-
2005
- 2005-01-14 HR HR20050040A patent/HRP20050040A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RS20050038A (en) | 2007-06-04 |
WO2004006888A2 (en) | 2004-01-22 |
UA89020C2 (ru) | 2009-12-25 |
EP1524965A2 (en) | 2005-04-27 |
AU2003248615B2 (en) | 2006-11-16 |
PL372771A1 (en) | 2005-08-08 |
RU2005104423A (ru) | 2006-01-27 |
RU2354387C2 (ru) | 2009-05-10 |
WO2004006888A3 (en) | 2004-04-29 |
HRP20050040A2 (en) | 2006-11-30 |
AU2003248615A1 (en) | 2004-02-02 |
US20060083759A1 (en) | 2006-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU782282B2 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
AU2002325192B2 (en) | Controlled agglomeration | |
EP2349336B1 (en) | Mesoporous material excipients for poorly aqueous soluble ingredients | |
EP2436377B1 (en) | Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same | |
US20020009496A1 (en) | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | |
EP1722821B1 (en) | Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same | |
CA3019257A1 (en) | A pharmaceutical formulation of palbociclib and a preparation method thereof | |
EP3437646A1 (en) | Oral preparation having exceptional elutability | |
WO2010133611A1 (en) | Solid drug dispersions | |
EP1929997A1 (en) | Oxcarbazepine formulations | |
EP2665466B1 (en) | Solid molecular dispersion of fesoterodine | |
BG105807A (bg) | Състави с контролирано освобождаване на бетахистин | |
CA2397942C (en) | Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation | |
SI21256A (sl) | Stabilizacija profila sproščanja učinkovin iz formulacije | |
JP4754485B2 (ja) | 共沈活性物質含有粒子 | |
SK279927B6 (sk) | Orálne pevné farmaceutické prípravky obsahujúce ge | |
KR20230096434A (ko) | 콜린알포세레이트를 포함하는 약학 제제 | |
Nada et al. | Effect of raw materials on the formulation of norfloxacin tablets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF | Valid on the event date | ||
KO00 | Lapse of patent |
Effective date: 20120830 |